skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: DNA sequence and structure recognition by Fe(II)[center dot]bleomycin

Miscellaneous ·
OSTI ID:6964984

The bleomycins (BLMs) are a family of clinically-important antitumor antibiotics whose chemotherapeutic effects are believed to be expressed at the level of DNA degradation. Bleomycin-mediated DNA strand scission is sequence-selective, resulting in cleavage predominantly at [sup 5[prime]]GC[sup 3[prime]] and [sup 5[prime]]GT[sup 3[prime]] sequences. Several structurally-modified bithiazole derivatives equipped with appropriate DNA cleaving moieties have employed to investigate the role of the bithiazole ring system in bleomycin's sequence-selective recognition of DNA. The DNA cleaving moieties included Fe(II) [center dot] EDTA and chelated Co(II). Fe(II) [center dot] EDTA bithiazoles were shown to bind to DNA and mediate DNA strand scission in a sequence-neutral fashion. The Co(II) [center dot] bithiazole A[sub 2] complex induced alkali-labile lesions on duplex DNA; subsequent base treatment resulted in guanine-specific DNA strand scission. DNA damage induced by the CO(II) [center dot] bithiazole A[sub 2] complex was oxygen-dependent, although insensitive to inhibitors of activated forms of oxygen. A mechanistic study of DNA strand scission mediated by the Co(II) [center dot] bithiazole A[sub 2] complex resulted form preferential reactivity at guanine sites, as opposed to a guanine binding selectivity of the bithiazole. The ability of a DNA triple helix to serve as a substrate for Fe(II) [center dot] BLM for the 5[prime]-junction appeared to derive from recognition of a minor groove shape within this sequence, as opposed to intercalation at the junction. This was supported by the observation that Fe(II) [center dot] phleomycin, which is structurally unable to intercalate into DNA, exhibited the same selectivity of triplex cleavage as Fe(II) [center dot] BLM. Cleavage of the DNA triplex could be carried out in the presence of 5 mM Mg(II), suggesting the potential therapeutic relevance of this nucleic acid target for Fe(II) [center dot] BLM.

Research Organization:
Virginia Univ., Charlottesville, VA (United States)
OSTI ID:
6964984
Resource Relation:
Other Information: Thesis (Ph.D.)
Country of Publication:
United States
Language:
English